Tetra-n-propylporphycene as a tumour localizer: pharmacokinetic and phototherapeutic studies in mice.

The porphin isomer tetra-n-propyl-porphycene (TPP) was incorporated into unilamellar liposomes of dipalmitoylphosphatidylcholine and intravenously injected at a dose of 2 mg/kg to BALB/c mice bearing a MS-2 fibrosarcoma. Pharmacokinetic studies show that TPP is selectively transported by serum lipoproteins and delivered to the tumour tissue with good efficiency (approx. 1 microgram of the TPP per g of tissue at 24 h after injection) and selectivity (ratio of TPP concentration in the tumour to the peritumoural tissue 16.7 at 24 h). Large doses of TPP are also accumulated by the liver, in agreement with the elimination of the drug via the biliary route, while no TPP is recovered from the brain. Red light-irradiation (300 J/cm2) of the tumour area caused extensive necrosis, while only little cutaneous photosensitivity was observed. Since TPP has a large absorbance in the 630-640 nm region, can be synthesized with a high degree of purity and is an efficient generator of singlet oxygen, this drug represents a potential candidate as a phototherapeutic agent for tumours.

[1]  T. Dougherty,et al.  Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. , 1981, Cancer research.

[2]  D. Kessel,et al.  HEMATOPORPHYRIN and HPD: PHOTOPHYSICS, PHOTOCHEMISTRY and PHOTOTHERAPY , 1984, Photochemistry and photobiology.

[3]  G. Jori,et al.  Role of high-, low- and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo. , 1986, Cancer letters.

[4]  E. Vogel,et al.  Porphycen – ein neuartiges Porphin‐Isomer , 1986 .

[5]  E. Reddi,et al.  Preferential delivery of liposome-incorporated porphyrins to neoplastic cells in tumour-bearing rats. , 1983, British Journal of Cancer.

[6]  E. Vogel,et al.  2,7,12,17‐Tetrapropylporphycene—Counterpart of Octaethylporphyrin in the Porphycene Series , 1987 .

[7]  K Schaffner,et al.  THE PHOTOPHYSICAL PROPERTIES OF PORPHYCENES: POTENTIAL PHOTODYNAMIC THERAPY AGENTS * , 1986, Photochemistry and photobiology.

[8]  E. Reddi,et al.  ULTRASTRUCTURAL STUDIES ON THE MECHANISM OF THE PHOTODYNAMIC THERAPY OF TUMORS , 1987, Photochemistry and photobiology.

[9]  E. Vogel,et al.  2,7,12,17‐Tetrapropylporphycen — Pendant des Octaethylporphyrins in der Porphycen‐Reihe , 1987 .

[10]  G. Zalar,et al.  Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin. , 1977, Archives of dermatology.

[11]  E. Vogel,et al.  The photophysical properties of porphycene incorporated in small unilamellar lipid vesicles , 1989 .